Shares of Irhythm Technologies Inc (NASDAQ:IRTC) have been given a consensus broker rating score of 1.13 (Strong Buy) from the four analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and three have issued a strong buy recommendation on the company.
Analysts have set a 12-month consensus price target of $34.75 for the company and are forecasting that the company will post ($0.35) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Irhythm Technologies an industry rank of 172 out of 265 based on the ratings given to its competitors.
IRTC has been the subject of a number of research analyst reports. Zacks Investment Research cut shares of Irhythm Technologies from a “hold” rating to a “sell” rating in a research report on Friday, March 17th. Canaccord Genuity reiterated a “buy” rating and set a $40.00 price objective on shares of Irhythm Technologies in a research report on Monday, April 10th.
Shares of Irhythm Technologies (NASDAQ:IRTC) traded up 0.66% during mid-day trading on Thursday, reaching $33.56. 776,714 shares of the company’s stock traded hands. The firm’s market cap is $743.42 million. Irhythm Technologies has a 52 week low of $22.16 and a 52 week high of $40.48. The company’s 50 day moving average is $36.09 and its 200-day moving average is $31.54.
Irhythm Technologies (NASDAQ:IRTC) last released its quarterly earnings data on Wednesday, February 15th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.28) by $0.09. The company had revenue of $18.70 million for the quarter, compared to analyst estimates of $17.33 million. Equities analysts expect that Irhythm Technologies will post ($1.17) earnings per share for the current fiscal year.
A number of large investors have recently bought and sold shares of the company. Columbus Circle Investors acquired a new stake in Irhythm Technologies during the first quarter worth $714,000. Teachers Advisors LLC acquired a new stake in Irhythm Technologies during the fourth quarter worth $373,000. UBS Asset Management Americas Inc. acquired a new stake in Irhythm Technologies during the fourth quarter worth $741,000. Perceptive Advisors LLC acquired a new stake in Irhythm Technologies during the fourth quarter worth $10,567,000. Finally, Janus Capital Management LLC acquired a new stake in Irhythm Technologies during the fourth quarter worth $3,011,000. 3.65% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This piece of content was reported by WKRB News and is the property of of WKRB News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at http://www.wkrb13.com/markets/2065591/irhythm-technologies-inc-irtc-receives-average-rating-of-strong-buy-from-brokerages.html.
Irhythm Technologies Company Profile
iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2065591/irhythm-technologies-inc-irtc-receives-average-rating-of-strong-buy-from-brokerages.html
Receive News & Ratings for Irhythm Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.